Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.

Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1053-9. doi: 10.1016/j.ijrobp.2015.04.039. Epub 2015 May 1.

PMID:
26194680
2.

How Low Should You Go: Choice of Minimum Dose Prescription in Cranial Radiosurgery.

Roberge D, Leclerc-Champagne C, Doucet R, Seuntjens J.

Cureus. 2015 Jun 29;7(6):e282. doi: 10.7759/cureus.282. eCollection 2015 Jun.

3.

Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.

Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):602-612. doi: 10.1016/j.ijrobp.2015.02.013. Review.

PMID:
26068493
4.

Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy.

Mathieu D, Campeau MP, Bahig H, Larrivée S, Vu T, Lambert L, Lavoie C, Roberge D, Doucet R, Carrier JF, Gorgos A, Fortin B, Filion E.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):e365-73. doi: 10.1016/j.prro.2014.12.002. Epub 2015 Feb 11.

PMID:
25680997
5.

Turn down the noise-a blinded evaluation of iterative image reconstruction in radiation therapy computed tomography simulation.

Nguyen NT, Charron G, Blais D, Roberge D.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):e393-400. doi: 10.1016/j.prro.2014.12.006. Epub 2015 Feb 7.

PMID:
25666989
6.

Who gets a family physician through centralized waiting lists?

Breton M, Brousselle A, Boivin A, Roberge D, Pineault R, Berbiche D.

BMC Fam Pract. 2015 Feb 5;16:10. doi: 10.1186/s12875-014-0220-7.

7.

Latent uncertainties of the precalculated track Monte Carlo method.

Renaud MA, Roberge D, Seuntjens J.

Med Phys. 2015 Jan;42(1):479-90. doi: 10.1118/1.4903502.

PMID:
25563287
8.

Shifting chemical equilibria in flow--efficient decarbonylation driven by annular flow regimes.

Gutmann B, Elsner P, Glasnov T, Roberge DM, Kappe CO.

Angew Chem Int Ed Engl. 2014 Oct 20;53(43):11557-61. doi: 10.1002/anie.201407219. Epub 2014 Sep 4.

PMID:
25196172
9.

Evaluation of the implementation of centralized waiting lists for patients without a family physician and their effects across the province of Quebec.

Breton M, Brousselle A, Boivin A, Loignon C, Touati N, Dubois CA, Nour K, Berbiche D, Roberge D.

Implement Sci. 2014 Sep 4;9:117. doi: 10.1186/s13012-014-0117-9.

10.

Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis.

Bahig H, Filion E, Vu T, Roberge D, Lambert L, Bouchard M, Lavoie C, Doucet R, Nadeau D, Chalaoui J, Campeau MP.

Technol Cancer Res Treat. 2014 Jun 30. [Epub ahead of print]

PMID:
24988054
11.

Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.

Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):804-13. doi: 10.1016/j.ijrobp.2014.03.041.

12.

Conditions for production of interdisciplinary teamwork outcomes in oncology teams: protocol for a realist evaluation.

Tremblay D, Touati N, Roberge D, Denis JL, Turcotte A, Samson B.

Implement Sci. 2014 Jun 17;9:76. doi: 10.1186/1748-5908-9-76.

13.

An exploration of rural-urban differences in healthcare-seeking trajectories: implications for measures of accessibility.

Haggerty JL, Roberge D, Lévesque JF, Gauthier J, Loignon C.

Health Place. 2014 Jul;28:92-8. doi: 10.1016/j.healthplace.2014.03.005. Epub 2014 May 3.

PMID:
24793139
14.

Kinetics of myxoid liposarcoma radiation response and effects on radiation dose delivery.

Vakilian S, Freeman C, Al-Suhaibani A, Roberge D.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):180-5. doi: 10.1016/j.prro.2012.06.005. Epub 2012 Jul 17.

PMID:
24674362
15.

Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas.

Skamene SR, Rakheja R, Dahlstrom KR, Roberge D, Nahal A, Charest M, Turcotte R, Hickeson M, Freeman C.

J Surg Oncol. 2014 Apr;109(5):410-4. doi: 10.1002/jso.23523. Epub 2013 Dec 6. Erratum in: J Surg Oncol. 2015 Jun;111(7):929. Dalhstrom, Kristina R [Corrected to Dahlstrom, Kristina R].

PMID:
24310279
16.

Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications.

Valentine K, Cabrera T, Roberge D.

Technol Cancer Res Treat. 2014 Jun;13(3):253-8. doi: 10.7785/tcrt.2012.500378. Epub 2013 Sep 20.

PMID:
24066955
17.

The cancer patient's use and appreciation of the internet and other modern means of communication.

Katz JE, Roberge D, Coulombe G.

Technol Cancer Res Treat. 2014 Oct;13(5):477-84. doi: 10.7785/tcrtexpress.2013.600267. Epub 2013 Aug 31.

PMID:
24000994
18.

Skin elasticity as a measure of radiation fibrosis: is it reproducible and does it correlate with patient and physician-reported measures?

Nguyen NT, Roberge D, Freeman C, Wong C, Hines J, Turcotte RE.

Technol Cancer Res Treat. 2014 Oct;13(5):469-76. doi: 10.7785/tcrtexpress.2013.600257. Epub 2013 Aug 31.

PMID:
24000984
19.

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen SM, Mehta MP, Watkins-Bruner D; Radiation Therapy Oncology Group (RTOG).

Neuro Oncol. 2013 Oct;15(10):1429-37. doi: 10.1093/neuonc/not114. Epub 2013 Aug 16.

20.

Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.

Bahig H, Campeau MP, Vu T, Doucet R, Béliveau Nadeau D, Fortin B, Roberge D, Lambert L, Carrier JF, Filion E.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):583-9. doi: 10.1016/j.ijrobp.2013.06.2048. Epub 2013 Aug 14.

PMID:
23953636
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk